Once-Daily Beta-Agonist for COPD Earns FDA Panel Support

SILVER SPRING, MD. (IMNG) - Olodaterol, an inhaled long-acting beta2-adrenergic agonist, is an effective bronchodilator and should be approved for the treatment of chronic obstructive pulmonary disease,...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news